Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

229
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
229
Connective Tissue Cell Types01:22

Connective Tissue Cell Types

3.4K
Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
3.4K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

429
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
429
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

1.3K
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Divergent Thermal Feedbacks of Urbanization and Greening Modulate the Urban Heat Island in 21st-Century China.

Environmental science & technology·2026
Same author

Two Fatty Acids From Host Plant Leaves Are Attractive to Soritia leptatina Adults.

Journal of chemical ecology·2026
Same author

Conventional preoperative parameters associated with new-onset atrial fibrillation after TAVR: a comparative single-center study.

Journal of cardiothoracic surgery·2026
Same author

Investigating <i>InDels</i> in <i>YAP</i> and <i>TAZ</i> genes and their impact on growth characteristics in goats.

Archives animal breeding·2026
Same author

Use of Machine-Learning Models to Identify Clinical Features Associated With A Future Clinical Worsening Event in Patients With Pulmonary Arterial Hypertension.

Pulmonary circulation·2026
Same author

Rapid evaluation and mechanistic study of the whitening activity of dandelion extract based on UV-Vis spectroscopy.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026

Related Experiment Video

Updated: May 3, 2026

Author Spotlight: Integrating Mechanical and Biological Analysis in Tendinopathy Research
04:37

Author Spotlight: Integrating Mechanical and Biological Analysis in Tendinopathy Research

Published on: March 1, 2024

1.6K

Is Statin Use Associated With Tendon Rupture? A Population-Based Retrospective Cohort Analysis.

Tahmeed Contractor1, Abhimanyu Beri, Joseph C Gardiner

  • 11Division of Cardiology, Lehigh Valley Health Network, Allentown, PA; 2Department of Clinical Cardiac Electrophysiology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA; 3Department of Epidemiology and Biostatistics, Michigan State University, East Lansing, MI; 4Center for Health Research, Geisinger Health System, Danville, PA; and 5Department of Medicine, Michigan State University, East Lansing, MI.

American Journal of Therapeutics
|January 24, 2014
PubMed
Summary

Statins, or 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors (HMG-CoA-Is), do not appear to increase the risk of tendon rupture. This large population study found no significant difference in tendon rupture rates between HMG-CoA-I users and nonusers.

Related Experiment Videos

Last Updated: May 3, 2026

Author Spotlight: Integrating Mechanical and Biological Analysis in Tendinopathy Research
04:37

Author Spotlight: Integrating Mechanical and Biological Analysis in Tendinopathy Research

Published on: March 1, 2024

1.6K

Area of Science:

  • Pharmacology
  • Clinical Epidemiology
  • Musculoskeletal Health

Background:

  • Case reports and small studies have raised concerns about a potential link between statin use (HMG-CoA-Is) and tendon rupture.
  • A definitive, large-scale assessment of this risk is needed to clarify the association.

Purpose of the Study:

  • To evaluate the association between the use of 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors (HMG-CoA-Is) and the risk of tendon rupture.
  • To determine if HMG-CoA-I initiation is linked to an increased incidence of tendon rupture in a large, insured population.

Main Methods:

  • A population-based retrospective cohort study was conducted using a private insurance database of approximately 800,000 enrollees.
  • Patients aged ≤64 years with continuous enrollment for at least 1 year were selected. Exposure was defined as HMG-CoA-I initiation.
  • Each exposed patient was matched with two controls of similar age and gender. Incidence rate ratios for tendon rupture were assessed after adjusting for baseline characteristics and follow-up differences.

Main Results:

  • The study included 34,749 HMG-CoA-I exposed patients matched with 69,498 controls.
  • No statistically significant difference in the occurrence of tendon ruptures was observed between the HMG-CoA-I user group and the nonuser control group.
  • This finding remained consistent even after adjusting for age, gender, and other known risk factors for tendon rupture.

Conclusions:

  • This large-scale, population-based retrospective cohort evaluation suggests that 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors (HMG-CoA-Is) as a drug class are not associated with an increased risk of tendon rupture.
  • The findings help to alleviate concerns regarding statin-associated tendon rupture in clinical practice.
  • Further research may explore specific patient populations or rare adverse events, but the overall association appears negligible.